ZGGS34

· Suzhou Zelgen Biopharmaceuticals Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ZGGS34, covering 2025-12-02 to 2025-12-02. Get the full timeline:

Most recent: Clinical Trial Update: Study of ZGGS34 in Participants With Advanced Solid Tumors [Phase 1, Phase 2]